Perfil
Lin Ni is currently the Managing Director at 6 Dimensions Capital since 2017 and an Independent Non-Executive Director at TenNor Therapeutics Suzhou Ltd. starting in 2025.
Former positions include Managing Director at Frontline Bioventures, Director at Shanghai Ark Biopharmaceutical Co., Ltd. in 2021, and Non-Executive Director at Edding Genor Group Holdings Ltd. from 2021 to 2022.
Education includes a doctorate degree from Osaka University conferred in 2009.
Cargos activos de Lin Ni
| Empresas | Cargo | Inicio |
|---|---|---|
| TENNOR THERAPEUTICS (SUZHOU) LIMITED | Director/Miembro de la Junta | 08/07/2025 |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Inversor de Capital Privado | 18/05/2017 |
Antiguos cargos conocidos de Lin Ni.
| Empresas | Cargo | Fin |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Director/Miembro de la Junta | 29/07/2022 |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Director/Miembro de la Junta | 18/05/2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Director/Miembro de la Junta | - |
Formación de Lin Ni.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Health Technology |
TenNor Therapeutics Suzhou Ltd.
TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
Genor Biopharma Holdings Ltd.
Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
- Bolsa de valores
- Insiders
- Lin Ni
















